2022 | | A partially hydrolyzed whey formula provides adequate nutrition in high-risk infants for allergy | 이수영, 정경욱 |
2018 | | A party to celebrate having an article published | 정민석 |
2019 | | A Path Analysis of Effects of Patients' Underlying Conditions, Treatment Satisfaction, and Adherence on Quality of Life Among Korea Glaucoma Patients | 안재홍 |
2011 | | A Path Model Predicting Medication Adherence and Self-care of Low-income Older Adults with Hypertension | 이은현 |
2015 | | A patient with atonic seizures mimicking transient ischemic attacks. | 안영실, 최준영 |
2008 | | A Patient with Frontotemporal Dementia Presenting with Limb-Kinetic Apraxia | 문소영 |
2016 | | A Patient with Henoch-Schönlein Purpura with Intussusception and intractable Nephritis | 배기수, 임현이, 홍정 |
2009 | | A Patient’s Right to Know and Self-Determination | 김용순, 방경숙, 유문숙 |
2008 | | A Patterns of Care Study of the Various Radiation Therapies for Prostate Cancer among Korean Radiation Oncologists in 2006 | 오영택 |
2020 | | A peptide derived from the core beta-sheet region of TIRAP decoys TLR4 and reduces inflammatory and autoimmune symptoms in murine models | 서창희 |
2004 | | A phagemid system enabling easy estimation of the combinatorial antibody library size. | 권명희, 김경민, 박선, 신호준 |
2016 | | A Phantom Study for Attenuation Change and Detection of Calcification in Lung Nodules According to Variation of Examination Techniques in Low Dose CT | 조재용 |
2018 | | A pharmaceutical composition for preventing or treating neurodegenerative diseases comprising inhibitor for expressing or activating of FcgammaRIIB | 박상면 |
2018 | | A pharmaceutical composition for preventing or treating neurodegenerative diseases comprising inhibitor for expressing or activating of SHP-1/-2 | 박상면 |
2007 | | A pharmaceutical composition for the treatment of allergic diseases and chronic inflammatory diseases | 남동호 |
2010 | | A pharmaceutical composition for the treatment or prevention of allergic disease and autoimmune disease, use thereof, and a method for treatment or prevention of allergic disease and autoimmune disease | 남동호 |
2020 | | A pharmacokinetic evaluation of the rituximab biosimilar CT-P10 in the treatment of rheumatoid arthritis | 서창희 |
2015 | | A phase 2 multi-center, open-label, switch-over trial to evaluate the safety and efficacy of Abcertin® in patients with type 1 Gaucher disease. | 손영배 |
2014 | | A phase 2 trial of radiation therapy with concurrent paclitaxel chemotherapy after surgery in patients with high-risk endometrial cancer: a Korean Gynecologic Oncologic Group study. | 유희석 |
2016 | | A Phase 2a Study of Benralizumab for Patients with Eosinophilic Asthma in South Korea and Japan | 박해심 |